PCLNX
Price
$6.49
Change
-$0.05 (-0.76%)
Updated
Dec 19 closing price
RYMEX
Price
$29.23
Change
-$0.07 (-0.24%)
Updated
Dec 19 closing price
Ad is loading...

PCLNX vs RYMEX

Header iconPCLNX vs RYMEX Comparison
Open Charts PCLNX vs RYMEXBanner chart's image
PIMCO CommoditiesPLUS® Strategy I-3
Price$6.49
Change-$0.05 (-0.76%)
VolumeN/A
CapitalizationN/A
Rydex Commodities Strategy A
Price$29.23
Change-$0.07 (-0.24%)
VolumeN/A
CapitalizationN/A
PCLNX vs RYMEX Comparison Chart
Loading...
View a ticker or compare two or three
VS
PCLNX vs. RYMEX commentary
Dec 20, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PCLNX is a Hold and RYMEX is a Hold.

FUNDAMENTALS
Fundamentals
PCLNX has more cash in the bank: 4.32B vs. RYMEX (3.78M). RYMEX pays higher dividends than PCLNX: RYMEX (4.53) vs PCLNX (2.31). PCLNX was incepted earlier than RYMEX: PCLNX (7 years) vs RYMEX (20 years). RYMEX has a lower initial minimum investment than PCLNX: RYMEX (2500) vs PCLNX (1000000). PCLNX annual gain was more profitable for investors over the last year : 5.25 vs. RYMEX (3.80). PCLNX return over 5 years is better than : 70.49 vs. RYMEX (31.83).
PCLNXRYMEXPCLNX / RYMEX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence7 years20 years-
Gain YTD6.5615.182127%
Front LoadN/AN/A-
Min. Initial Investment1000000250040,000%
Min. Initial Investment IRAN/A1000-
Net Assets4.32B3.78M114,342%
Annual Yield % from dividends2.314.5351%
Returns for 1 year5.253.80138%
Returns for 3 years37.8928.80132%
Returns for 5 years70.4931.83221%
Returns for 10 yearsN/A-5.76-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FOLD9.730.16
+1.67%
Amicus Therapeutics
WNEB9.21-0.11
-1.18%
Western New England Bancorp
SMP31.02-0.56
-1.77%
Standard Motor Products
SIRI20.58-0.93
-4.32%
SiriusXM Holdings Inc
BCDA1.84-0.16
-8.00%
BioCardia Inc.